Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension
Gérald Simonneau(Inserm), David B. Badesch(University of Colorado Anschutz Medical Campus), Marjana Serdarevic-Pehar(Jagiellonian University), Mordechai R. Kramer(Rabin Medical Center), Gary Layton(University of Geneva), Nazzareno Galiè(Azienda USL di Bologna), Thomas R. Fleming(University of Washington), Olivier Sitbon(Inserm), Peter A. Engel(Christ Hospital), Lewis J. Rubin(University of California San Diego), Robyn J. Barst(Columbia University), Adaani Frost(Houston Methodist)
Cited by 28
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Survival in Patients with Primary Pulmonary Hypertension
|Annals of Internal Medicine|1991|3.5k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k